The GLP-1 Truth: Why 60% of Users Quit, What Science Really Says, and Who Should Consider Them
GLP-1 medications like Ozempic, Wegovy, and Zepbound have revolutionized weight loss and diabetes treatment, with 12% of American adults now using these drugs, yet up to 65% discontinue within the first year. This comprehensive guide breaks down the science behind GLP-1 drugs, explores their remarkable benefits beyond weight loss including cardiovascular and brain health protection, and reveals the real challenges like side effects and costs that cause high discontinuation rates. Whether you’re considering GLP-1 medications for yourself, advising clients as a fitness professional, or supporting a family member, discover who truly benefits from these breakthrough medications and how to maximize success with the right approach.



